FDA Drug Recalls

Recalls / Active ingredient / Pantoprazole Sodium

Pantoprazole Sodium

9 FDA drug recalls involving the active ingredient “Pantoprazole Sodium” — 1 Class I.

DateClassProductFirm
2023-09-05Class IIPantoprazole Sodium for Injection 40mg per vial, Single dose vials NDC 71839-122-01 Packaged as (a) 10 Single-BE PHARMACEUTICALS AG
2023-03-14Class IIPantoprazole Sodium Delayed Release Tablets USP 40mg, 1000-count bottles, Rx only, Manufactured for: Camber PhHetero USA Inc
2022-07-25Class IIPantoprazole Sodium for Delayed-Release Oral Suspension*40 mg* suspension in apple juice or applesauce only EaSUN PHARMACEUTICAL INDUSTRIES INC
2022-04-11Class IIPantoprazole Sodium Delayed-Release Tablets, USP, 20 mg, Rx Only, 90 tablets per bottle, Manufactured by: TorrTorrent Pharma Inc
2021-03-15Class IIPantoprazole Sodium Delayed-Release Tablets, USP 20 mg* 90 Tablets Rx Only NDC 62175-180-46 Distributed by: KrCardinal Health Inc.
2021-02-05Class IIIPantoprazole Sodium for Injection 40mg/vial For I.V. infusion only Distributed by: Sun Pharmaceutical IndustriSUN PHARMACEUTICAL INDUSTRIES INC
2017-12-04Class IPantoprazole Sodium for Injection, 40 mg per vial, single dose vial, Rx only, Manufactured in India for: AuroMAuroMedics Pharma LLC
2016-12-16Class IIIPantoprazole Sodium for Injection, 40mg per vial, Single-dose vial, Rx only, Mfd. in India for: Auromedics PAurobindo Pharma USA Inc
2016-11-22Class IIIPROTONIX I.V. (pantoprazole sodium) for Injection, Equivalent to 40 mg pantoprazole per vial, For I.V. infusioPfizer Inc.